Zobrazeno 1 - 10
of 118
pro vyhledávání: '"Shoji, Nagao"'
Autor:
Kazuhiro Okamoto, MD, Kotaro Yoshio, MD, PhD, Shinsuke Shirakawa, MD, Kyohei Irie, MD, Naoyuki Ida, MD, PhD, Hirofumi Matsuoka, MD, PhD, Junko Haraga, MD, PhD, Chikako Ogawa, MD, PhD, Keiichiro Nakamura, MD, PhD, Shoji Nagao, MD, PhD, Hisashi Masuyama, MD, PhD
Publikováno v:
Radiology Case Reports, Vol 18, Iss 7, Pp 2447-2451 (2023)
The abscopal effect is a rare phenomenon, in which tumor shrinkage in the nonirradiated metastatic region is observed after radiotherapy. Certainly, this response is sometimes reported with the combined use of immune-checkpoint inhibitors, but a pure
Externí odkaz:
https://doaj.org/article/ee554ecc0fc44219b905ceee071737ba
Autor:
Hiroaki Itamochi, Nobuhiro Takeshima, Junzo Hamanishi, Kosei Hasegawa, Motoki Matsuura, Kiyonori Miura, Shoji Nagao, Hidekatsu Nakai, Naotake Tanaka, Hideki Tokunaga, Shin Nishio, Hidemichi Watari, Yoshihito Yokoyama, Yoichi Kase, Shuuji Sumino, Ai Kato, Ajit Suri, Toshiaki Yasuoka, Kazuhiro Takehara
Publikováno v:
Journal of Gynecologic Oncology; Sep2024, Vol. 35 Issue 5, p1-12, 12p
Autor:
Munetaka Takekuma, Fumiaki Takahashi, Seiji Mabuchi, Wataru Kudaka, Koji Horie, Mariko Ikeda, Ayumi Shikama, Akira Mitsuhashi, Shoji Nagao, Shiro Suzuki, Mika Mizuno, Shin Nishio, Hideki Tokunaga, Yukinobu Ota, Takahiro Kasamatsu, Ryo Kitagawa, Takafumi Toita, Hiroaki Kobayashi, Mitsuya Ishikawa, Nobuo Yaegashi
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-13 (2020)
Abstract Background The aim of the current study was to evaluate oncologic outcomes of patients who were treated with salvage hysterectomy (HT), compared to systemic chemotherapy (CT) for persistent cervical cancer after definitive radiotherapy (RT)/
Externí odkaz:
https://doaj.org/article/5958a1e42ca5488ea88e90a03b91002c
Autor:
Shoji Nagao, Ai Kogiku, Kazuhiro Suzuki, Takashi Shibutani, Kasumi Yamamoto, Tomoatsu Jimi, Miho Kitai, Takaya Shiozaki, Kazuko Matsuoka, Satoshi Yamaguchi
Publikováno v:
Journal of Ovarian Research, Vol 13, Iss 1, Pp 1-6 (2020)
Abstract Introduction Bevacizumab and gemcitabine are key drugs for treating recurrent epithelial ovarian cancer. However, information about the combination of bevacizumab and gemcitabine is insufficient. We conducted a phase II study to assess the f
Externí odkaz:
https://doaj.org/article/56b247b2785d4f23af328e75e47c2117
Publikováno v:
Gynecology and Minimally Invasive Therapy, Vol 10, Iss 2, Pp 124-126 (2021)
We present a patient diagnosed with high-grade cervical intraepithelial neoplasia (CIN) combined with macroscopic lesions of the vaginal epithelium. There was no lesion in pelvic magnetic resonance imaging examination, and histopathological examinati
Externí odkaz:
https://doaj.org/article/825f13fa601c49c1b0f7a54371889bdf
Autor:
Shoji Nagao, Jun Tamura, Takashi Shibutani, Maiko Miwa, Tomoyasu Kato, Ayumi Shikama, Yuji Takei, Natsuko Kamiya, Naoki Inoue, Kazuto Nakamura, Aya Inoue, Koji Yamamoto, Keiichi Fujiwara, Mitsuaki Suzuki
Publikováno v:
International Journal of Clinical Oncology. 28:804-815
Introduction Three randomized controlled trials have resulted in extremely extensive application of the strategy of using neoadjuvant chemotherapy (NAC) followed by interval debulking surgery (IDS) for patients with advanced epithelial ovarian cancer
Autor:
Yusuke Kajimoto, Kazunori Honda, Shiro Suzuki, Masahiko Mori, Hirofumi Tsubouchi, Kohshiro Nakao, Anri Azuma, Takashi Shibutani, Shoji Nagao, Takahiro Koyanagi, Izumi Kohara, Shuko Tamaki, Midori Yabuki, Lida Teng, Keiichi Fujiwara, Ataru Igarashi
Publikováno v:
International Journal of Clinical Oncology. 28:454-467
Autor:
Mika Mizuno, Kimihiko Ito, Hidekatsu Nakai, Hidenori Kato, Shoji Kamiura, Kimio Ushijima, Shoji Nagao, Hirokuni Takano, Masao Okadome, Munetaka Takekuma, Hideki Tokunaga, Satoru Nagase, Daisuke Aoki, Robert L. Coleman, Yasuko Nishimura, Christine K. Ratajczak, Hideyuki Hashiba, Hao Xiong, Noriyuki Katsumata, Takayuki Enomoto, Aikou Okamoto
Publikováno v:
International Journal of Clinical Oncology. 28:163-174
Background The phase 3 VELIA trial evaluated veliparib with carboplatin/paclitaxel and as maintenance in patients with high-grade serous ovarian carcinoma. Methods Patients with previously untreated stage III–IV high-grade serous ovarian carcinoma
Autor:
Shoji Nagao, Keiichi Fujiwara, Kouji Yamamoto, Hiroshi Tanabe, Aikou Okamoto, Kazuhiro Takehara, Motoaki Saito, Hiroyuki Fujiwara, David S.P. Tan, Satoshi Yamaguchi, Sosuke Adachi, Akira Kikuchi, Takeshi Hirasawa, Takeshi Yokoi, Tomonori Nagai, Toyomi Sato, Shoji Kamiura, Akira Fujishita, Wong Wai Loong, Karen Chan, Peter Syks, Alexsander Olawaye, Sang-Young Ryu, Hiroyuki Shigeta, Eiji Kondo, Yoshihito Yokoyama, Takashi Matsumoto, Kosei Hasegawa, Takayuki Enomoto
Publikováno v:
NEJM Evidence. 2
Autor:
Hiroaki Kajiyama, Nobumasa Takagaki, Keisuke Matsusaki, Shigenobu Emoto, Kuniaki Aridome, Joji Kitayama, Takao Takahashi, Hiroshi Tsubamoto, Akihiro Watanabe, Shoji Nagao, Hideaki Shimada
Publikováno v:
International Journal of Clinical Oncology
Patients with peritoneal dissemination (PD) caused by abdominal malignancies are often associated with massive ascites, which shows extremely dismal prognosis because of the discontinuation of systemic chemotherapy mostly due to poor performance stat